Antinociceptive and morphine modulatory actions of spinal orphanin FQ

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 3, 1998, Pages 314-324

  Jhamandas, K H ^a   Sutak, M ^a   Henderson, G ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cross tolerance; Nociceptin; Opioid antagonism; Orphanin FQ; Spinal antinociception; Tolerance

Indexed keywords

BETA FUNALTREXAMINE; DELTORPHIN; MORPHINE; NOCICEPTIN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031846105     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-019     Document Type: Article

References (32)

1. Bunzow, J., Saez, C., Mortrud, M., Bouvier, C., Williams, J.T., Low, M., and Grandy, D.K. 1994. Molecular cloning and tissue distribution of a putative member of the rat opioid family that is not a μ, δ or κ opioid receptor type. FEBS Lett. 347: 284-288.
2. Caudle, R.M., and Isaac, L. 1988. Intrathecal dynorphin (1-13) results in an irreversible loss of the tail-flick reflex in rats. Brain Res. 453: 1-6.
3. D Amour, F.E., and Smith, D.C. 1941. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 74-79.
4. Dawson-Basoa, M., and Gintzler, A.R. 1997. Nociceptin (orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia. Brain Res. 750: 48-52.
5. Faber, E.S.L., Chambers, J.P., Evans, R.H., and Henderson, G. 1996. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmacol. 119: 189-190.
6. Gintzler, A.R. 1980. Endorphin-mediated increases in pain threshold during pregnancy. Science (Washington, D.C), 210: 193-195.
7. Giuliani, S., and Maggi, C.A. 1996. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmacol. 118: 1567-1569.
8. Gouàrderes, C., Sutak, M., Zajac, J.-M., and Jhamandas, K. 1993. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237: 73-81.
9. Gouàrderes, C., Jhamandas, K., Sutak, M., and Zajac, J.-M. 1996. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117: 493-501.
10. Han, J.S., and Xie, G.H. 1982. Dynorphin: potent analgesic effect in spinal cord of the rat. Life Sci. 31: 1784.
11. Henderson, G., and McKnight, A.T. 1997. The orphan receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18: 293-300.
12. 1-3, and a kappa-receptor agonist U50,488. Can. J. Physiol. Pharmacol. 64: 263-268.
13. Long, J.B., Rigamonti, D.D., deCosta, B., Rice, K.C., and Martinez-Arizala, A. 1989. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the λ opioid antagonist norbinaltorphimine. Brain Res. 497: 155-162.
14. Loomis, C.W., Cervenko, F.W., Jhamandas, K., Sutak, M., and Milne, B. 1985. Analgesia and autonomic function following intrathecal administration of morphine and norepinephrine to the rat. Can. J. Physiol. Pharmacol. 63: 656-662.
15. Loomis, C.W., Milne, B., and Cervenko, F.W. 1987. Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps. Pharmacol. Biochem. Behav. 26: 131-139.
16. Menard, P.D., Van Rossum, D., Kar, S., St. Pierre, S., Sutak, M., Jhamandas, K., and Quirion, R. 1996. A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J. Neurosci. 16: 2342-2351.
17. Meunier, J.-C., Mollereau, C., Toll, C., Moisand, C., Alvinerle, P., Butour, J., Gillemot, J.-C., Ferrara, P., Monsarrat, B., Mazarguil, H., Vassart, G., Parmentier, M., and Costentin, J. 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL 1 receptor. Nature (London), 377: 532-535.
18. Mogil, J.S., Grisel, J.E., Zhangs, G., Belknap, J.K., and Grandy, D.K. 1996a. Functional antagonism of μ, δ, and κ opioid antinociception by orphanin FQ. Neurosci. Lett. 214: 131-134.
19. Mogil, J.S., Grisel, J.E., Reinscheid, R.K., Civelli, O., Belknap, J.K., and Grandy, D.K. 1996b. Orphanin FQ is a functional anti-opioid peptide. Neuroscience, 75: 333-337.
20. Mollereau, C., Parmentier, M., Mailleux, P., Butour, J.L., Moisand, C., Chalon, P., Caput, D., Vassart, G., and Meunier, J.-C. 1994. ORL 1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341: 33-38.
21. Nicol, B., Lambert, D.G., Rowbotham, D.J., Smart, D., and McKnight, A.T. 1996. Nociceptin-induced inhibition of K evoked glutamate release from rat cerebrocortical slice. Br. J. Pharmacol. 119: 1081-1083.
22. Reinscheid, R.K., Nothacker, H.-P., Bourson, A., Ardati, A., Hensingen, R.A., Buznow, J.R., Grandy, D.K., Langen, H., Monsma, F.J., Jr., and Civelli, O. 1995. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science (Washington, D.C.), 270: 792-794.
23. Riedl, M., Shuster, S., Vulchanova, L., Wand, J., Loh., H.H., and Elde, R. 1996. Orphanin FQ/nociceptin immunoreactive nerve fibres parallel those containing endogenous opioids in rat spinal cord. NeuroReport, 7: 1369-1372.
24. Rivilin, A.S., and Tator, C.H. 1977. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47: 577-581.
25. Rossi, G., Leventhal, L., and Pasternak, G.W. 1996. Naloxone-sensitive orphanin FQ-induced analgesia in mice. Eur. J. Pharmacol. 311: R7-R8.
26. Stanfa, L.C., Chapman, V., Kerr, N., and Dickenson, A.H. 1996. Inhibitory action of nociceptin on spinal dorsal horn neurons of the rat, in vivo. Br. J. Pharmacol. 118: 1875-1877.
27. Tian, J.H., Xu, W., Fang, Y., Mogil, J.S., Grisel, J.E., Grandy, D.K., and Han, J.S. 1997. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain potentiation in spinal cord of rat. Br. J. Pharmacol. 120: 676-680.
28. 1) ligand, nociceptin, of inwardly rectifying conductance in dorsal raphe nucleus neurons. Br. J. Pharmacol. 117: 1609-1611.
29. Wang, J.B., Johnson, P.S., Imai, Y., Perisco, A.M, Ozensberger, B.A., and Eppler, C.M. 1994. cDNA cloning of an orphan opioid recep-tor gene family member and its splice variant. FEBS Lett. 348: 75-79.
30. Xu, X.J., Hao, J.X., and Wiesenfeld-Hallin, S. 1996. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport, 7: 2092-2094.
31. Yaksh, T.L., and Rudy, T.A. 1976. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17: 1031-1036.
32. Yoshimura, M., and North, R.A. 1983. Substantia gelatinosa neurons in vivo hyperpolarized by enkephalin. Nature (London), 305: 529-530.